Tag: Dr. Susan Molchan

6 9/22/2017

Four questions to ask when reading or writing about water fluoridation and IQ

12/12/2016

Ending journalism’s bad trip — why it’s important to communicate responsibly about the health effects of psychedelic drugs

1 11/29/2016

Off-label drug marketing: Who will decide what’s “truthful” when the evidence can’t be trusted?   

8/11/2016

Poking holes in Pokémon Go health benefit claims–including a study that didn’t exist

3 6/22/2016

What’s at stake in the FDA’s decision on eteplirsen, an experimental muscular dystrophy drug

3 5/23/2016

Inside the Sausage Factory of Drug Approval: Nuplazid (pimavanserin) coverage didn’t inspect closely enough

13 2/24/2016

TIME’s short memory on Alzheimer’s drug failures

4 2/3/2016

Missing in action: Did US journalists miss a huge opportunity to critically examine mental health screening?

3 9/14/2015

Low pulse = higher crime rate? Cause-and-effect confusion in heart rate/crime stories

6/3/2015

Former NEJM editors slam “backtrack” on conflict of interest